Serdar Bilici

Dr. Serdar Bilici

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 May 2022 in Graefe's Archive for Clinical and Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
SBSerdar Bilici
Serdar Bilici
ATAydin Toprak
Aydin Toprak
CBCagatay Buyukuysal
Cagatay Buyukuysal
SUSuat H. Ugurbas
Suat H. Ugurbas

11 February 2022 in Taiwan Journal of Ophthalmology
Verified
Journal Article
Open access
SBSerdar Bilici
Serdar Bilici
RDReşat Duman
Reşat Duman
After the revolutionary effect of optical coherence tomography (OCT) on ophthalmology practice, recent OCT-based technology OCT angiography (OCT-A) also has rapidly gained a wide clinical acceptance. OCT-A is a noninvasive, depth-resolved imaging tool for the evaluation of retinal vascular changes. Since its introduction, the understanding of retinal vascular diseases, pacychoroid spectrum diseases, and other diseases have been enriched in many ways. More importantly, OCT-A provides depth-resolved information that has never before been available. The whole spectrum of neuro-ophthalmological diseases shows consistent peripapillary and macular capillary changes with structural and functional correlation. The superficial and deeper retinal and choroidal vasculatures are affected depending on the nature of the disease process. Therefore, OCT-A play an important role in the diagnosis and management of optic nerve-related diseases as well. In this review, we summarized existing literature on the use of OCT-A in neuro-ophthalmological diseases such as arteritic anterior ischemic neuropathy, nonarteritic anterior ischemic neuropathy, papillitis, papilledema, multiple sclerosis. Currently, OCT-A has an important position as a useful, noninvasive tool in the evaluation of neuro-ophthalmologic diseases; however, OCT-A has several limitations regarding its technical capabilities in challenging neuro-ophthalmic cases. With the improvement in the technical capacity of OCT-A, it will have a more important place in the diagnosis and follow-up of neuro-ophthalmological diseases in future.

1 January 2024 in Arquivos Brasileiros de Oftalmologia
Verified
Journal Article
Open access
SBSerdar Bilici
Serdar Bilici
THTomurcuk Harbigil-Sever
Tomurcuk Harbigil-Sever
SUSuat Hayri Ugurbas
Suat Hayri Ugurbas
PURPOSE: Evaluation of lid contour and marginal peak point changes to compare outcomes of external levator advancement and Müller's muscle conjunctival resection surgery in unilateral ptosis. METHODS: We reviewed the charts of unilateral ptosis patients who underwent external levator advancement or Müller's muscle conjunctival resection. Eyelid contour analysis was conducted on preoperative and 6-month postoperative digital images. This was performed with the multiple margin reflex distances technique, measuring the vertical distance from a line intersecting the center of the pupil to the eyelid margin at 10 positions at 2 mm intervals. The marginal peak point changes were analyzed digitally using the coordinates of the peak point according to the pupil center. Each position's mean distance was compared preoperatively, postoperatively, and with the fellow eyelid. RESULTS: Sixteen patients underwent external levator advancement and 16 patients had Müller's muscle conjunctival resection. The mean margin reflex distance was improved by both techniques (1.46 vs. 2.43 mm and 1.12 vs. 2.25 mm, p=0.008 and p=0.0001 respectively) and approached that of the fellow eyelid (2.43 vs. 2.88 and 2.25 vs. 2.58 mm, p=0.23 and p=0.19, respectively). However, statistically significant lid margin elevation was limited to between the N6 and T6 points in the external levator advancement group. Whereas, significant elevation was achieved along the whole lid margin in the Müller's muscle conjunctival resection group. The marginal peak point was shifted slightly laterally in the external levator advancement group (p=0.11). CONCLUSIONS: Both techniques provide effective lid elevation, however, the external levator advancement's effect lessens toward the canthi while Müller's muscle conjunctival resection provides more uniform elevation across the lid margin. The margin reflex distance alone is not sufficient to reflect contour changes.

15 October 2024 in BMC Ophthalmology
Verified
Journal Article
Open access
PDF file
SBSerdar Bilici
Serdar Bilici
NSNeriman Selçuk
Neriman Selçuk
NKNuman Küçük
Numan Küçük
SUSuat Hayri Uğurbaş
Suat Hayri Uğurbaş
To evaluate the effects of serial intravitreal injections (IVI) on the ocular surface and meibomian glands in patients with neovascular age-related macular degeneration (nAMD). Patients receiving anti-vascular endothelial growth factor (anti-VEGF) agent injections for unilateral nAMD were included. Untreated fellow eyes served as the control group. All participants followed a pre-IVI asepsis protocol with povidone-iodine (PI). Ocular surface diseases index (OSDI) questionnaire scores, first and average non-invasive tear break-up time (fNITBUT and avgNITBUT), Schirmer-1 test results, corneal staining score (according to Oxford scale), meibomian gland (MG) loss rates of lower and upper eyelids were recorded four weeks after the last IVI. Forty-two nAMD patients with a mean age of 63.3 ± 19.4 were included in the study. The mean OSDI score was 20.3 and the median of IVI number was 9 (6–22). There were no statistically significant difference between treated and untreated fellow eyes regarding fNITBUT (5.6 vs. 4.5, p = 0.872), avgNITBUT (6.2 vs. 7.2, p = 0.968), Shirmer-1 results (7 vs. 7, p = 0.854), corneal staining (0.3 vs. 0.2, p = 0.341), lower and upper MG loss rate (29.3 vs. 28.4, p = 0.162, and 27.1 vs. 26.9, p = 0.476, respectively). Only significant correlation was observed between age with lower and upper MG loss rate (r:0.396, p = 0.042, and r:0.365, p = 0.047). The results of the present study demonstrated that serial IVI of anti-VEGF agents with PI asepsis is well tolerated by nAMD patients in terms of ocular surface, MG loss and DED measurements.

7 October 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SBSerdar Bilici
Serdar Bilici
ATAydın Toprak
Aydın Toprak
MKMine Koru-Toprak
Mine Koru-Toprak
SUSuat Hayri Ugurbas
Suat Hayri Ugurbas
Swimming goggles (SG) are widely used in water sports, and this study aimed to evaluate the acute effects of wearing SG on intraocular pressure (IOP), anterior chamber biometrics, axial length (AL), and optic nerve head (ONH) morphology. Twenty-eight healthy young adults participated in this cross-sectional study, with assessed parameters including IOP, central corneal thickness (CCT), anterior chamber depth (ACD), anterior chamber angle (ACA), AL, and optical coherence tomography (OCT) imaging of the ONH, specifically Bruch membrane opening (BMO), Bruch membrane opening-minimum rim width (BMO-MRW), lamina cribrosa depth (LCD), and prelaminar tissue (PLT). Measurements were taken at four time points: before wearing SG, at the 1st and 10th minutes of wearing, and immediately after removal. The results showed a significant increase in IOP at the 1st and 10th minutes of SG wear compared to pre-wear and post-removal values. Additionally, decreases in CCT, ACD, and ACA, along with an increase in AL, were observed while wearing SG. However, these changes reverted to baseline after the goggles were removed. No significant alterations were detected in ONH parameters during the study. The findings suggest that wearing SG induces an acute rise in IOP and changes in anterior segment parameters, likely due to oculopression, but does not appear to affect ONH morphology in the short term. Further studies are needed to investigate any potential long-term effects.

18 April 2025 in BMC Ophthalmology
Verified
Journal Article
Open access
PDF file
SBSerdar Bilici
Serdar Bilici
KEKardelen Ezgi Şahin Elarslan
Kardelen Ezgi Şahin Elarslan
NKNuman Küçük
Numan Küçük
SUSuat Hayri Uğurbaş
Suat Hayri Uğurbaş
Background: To assess the role of inflammation in the pathogenesis of idiopathic epiretinal membrane (iERM) by evaluating blood-count-derived inflammatory marker levels. Methods: The medical records of patients diagnosed with iERM and cataract patients with normal fundus examinations were analyzed retrospectively. Levels of neutrophils, monocytes, lymphocytes, and thrombocytes were obtained from blood samples. Systemic inflammatory markers, including neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), and systemic inflammatory response index (SIRI) were calculated and compared between the two groups. The receiver operating characteristic curve (ROC) analysis was performed to determine the best cutoff value of NLR, PLR, SII, and SIRI in iERM. Results: In total, 91 iERM cases and 95 controls were included in the study. iERM patients had significantly higher NLR (2.25 vs. 1.91, p = 0.003), PLR (117.22 vs. 113.33, p = 0.042), SII (529.45 vs. 472.57, p = 0.003), and SIRI (1.25 vs. 0.90, p < 0.001). The area under the curve of NLR, PLR, SII, and SIRI in differentiating patients with iERM and controls was 0.637, 0.608, 0.645 and 0.660, respectively, according to ROC analysis. The best cutoff values (with sensitivity and specificity) were 1.95 (60.4% and 52.6%) for NLR, 116.7 (54.9% and 55.7%) for PLR, 498.03 (58.2% and 58.9%) for SII, and 1.07 (62.6% and 64.6%) for SIRI.No significant differences in inflammatory markers were found across iERM stages. Conclusion: Patients with iERM exhibit higher levels of blood-count-derived inflammatory markers, suggesting a link between systemic subclinical inflammation and iERM development. However, these markers do not correlate with iERM severity. Further research with larger cohorts and broader inflammatory marker analysis is needed to elucidate the role of systemic inflammation in iERM pathogenesis.